Cent Eur J Public Health 2007, 15(2):71-73 | DOI: 10.21101/cejph.a3411

Screenig Evaluation Systeme-Europe (SESy_Europe) Met Skin Cancer Screening

Vasiliki Karampoiki1, Francisco Javier Rivas Flores2, Hilal Altinoz3, Marzanna Chojnacka4, Irini Karentzou5, Mario Dambrosio6, Camelia Colichi7, Tamara Oxiuzova8, Eleni Kanavoura8, Berta Adelaide Maia da Silva Alves de Sousa9, Diana Ivanova1, Jacopo Mauri10, Georgios Alexiou1, Davide Mauri1,11, Konstantinos Kamposioras8, Angeliki Maragkaki1, Christina Peponi1
1 PACMeR sections of Dermatology, Oncology and Public Health, Athens, Greece
2 San Rafael Hospital, Clinic Documentation, Madrid, Spain
3 SSK Sureyyapasa, Thoracic Disease Center, Istanbul, Turkey
4 Maria Sklodowska-Curie Memorial Cancer Center, Dept Radiation Oncology, Warsaw, Poland
5 Cologne University school of Medicine, Cologne, Germany
6 Multimedica Hospital, Dept. Oncology, Milan, Italy
7 Department of Medical Oncology, Institute of Oncology, Bucharest, Romania
8 Ioannina University Hospital, Ioannina, Greece
9 Department of Medical Oncology, Portuguese Oncology Institute (IPOPFG-EPE), Porto, Portugal
10 PACMeR, Engineering and Development section, Milan, Italy
11 Department of Medical Oncology, Papageorgiou Hospital, Thessaloniki, Greece

Skin tumors are the most frequent malignancies in the white population worldwide and have reached the proportion of an epidemic disease. Since non-melanocytic skin cancers can be cured when timely detected, given that still malignant melanoma may have good prognosis if early diagnosed, and considering the key role of primary care in cancer screening advising and implementation, the international PACMeR study group (trial_01.3) adjourned SESy_Europe database in a version comprehensive of skin-malignancies screening indexing. The novel database provides standardized pre-codified translations of 2,331 parameters in eight languages (English, French, German, Greek, Italian, Romanian, Spanish and Turkish) and records the time elapsed from last skin examination, cause and frequency of skins examinations and stratifies skin cancer risk patterns by a systematic registering of risk factors.
A comprehensive indexing of skin cancer screening practices among European countries may in fact turn helpful in programming future health policy and tailoring interventions.

Keywords: skin cancer, melanoma, screening

Received: September 5, 2006; Revised: December 12, 2006; Accepted: December 12, 2006; Published: June 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Karampoiki V, Rivas Flores FJ, Altinoz H, Chojnacka M, Karentzou I, Dambrosio M, et al.. Screenig Evaluation Systeme-Europe (SESy_Europe) Met Skin Cancer Screening. Cent Eur J Public Health. 2007;15(2):71-73. doi: 10.21101/cejph.a3411. PubMed PMID: 17645221.
Download citation

References

  1. Mauri D, Pazarlis P, Mauri J, Altinoz H, Rivas Flores FJ, Karentzou I, et al. SESy-Europe: a multi-language database dedicated to cancer screening monitoring. J Exp Clin Cancer Res. 2004 Sep;23(3):441-5.
  2. Mauri J, Mauri D, Pazarlis P, Altinoz H, Rivas Flores FJ, Karentzou I, et al. PC 3-component database for community-based medical trials. A cost-effective solution for both voluntary associations and institutions of the EmergingWorld. Gazz Med Ital -Arch Sci Med. 2004 Oct;163(5):18994.
  3. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002 Apr;146 Suppl 61:1-6. Go to original source...
  4. MacKie RM.Awareness, knowledge and attitudes to basal cell carcinoma and actinic keratoses among the general public within Europe. J EurAcad Dermatol Venereol. 2004 Sep;18(5):552-5. Go to original source... Go to PubMed...
  5. Halpern AC, Hanson LJ. Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians. Int J Dermatol. 2004 Sep;43(9):638-42. Go to original source...
  6. de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer. 2004 Nov;40(16):2355-66. Go to original source... Go to PubMed...
  7. de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer. 2003 Oct 20;107(1):119-26. Go to original source... Go to PubMed...
  8. Marks R. Campaigning for melanoma prevention: a model for a health education program. J Eur Acad Dermatol Venereol. 2004 Jan;18(1):447. Go to original source...
  9. Altman JF, Oliveria SA, Christos PJ, HalpernAC.Asurvey of skin cancer screening in the primary care setting: a comparison with other cancer screenings. Arch Fam Med. 2000 Nov-Dec;9(10):1022-7. Go to original source...
  10. Kirsner RS, Muhkerjee S, Federman DG. Skin cancer screening in primary care: prevalence and barriers. JAmAcad Dermatol. 1999 Oct;41(4):5646. Go to original source...
  11. Federman DG, Concato J, Caralis PV, Hunkele GE, Kirsner RS. Screening for skin cancer in primary care settings. Arch Dermatol. 1997 Nov;133(11):1423-5. Go to original source... Go to PubMed...
  12. Revenga Arranz F, Paricio Rubio JF, Mar Vazquez Salvado M, del Villar Sordo V. Descriptive epidemiology of basal cell carcinoma and cutaneous squamous cell carcinoma in Soria (north- eastern Spain) 1998-2000: a hospital based survey. J EurAcad Dermatol Venereol. 2004 Mar;18(2):137-41. Go to original source...
  13. Nijsten T, Leys C, Verbruggen K, Verlinden V, Drieghe J, Stas M, et al. Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination. J EurAcad Dermatol Venereol. 2005 May;19(3):332-9. Go to original source... Go to PubMed...